Publicaciones (235) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Lipid fingerprint-based histology accurately classifies nevus, primary melanoma, and metastatic melanoma samples

    International Journal of Cancer, Vol. 154, Núm. 4, pp. 712-722

  2. Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)

    Hepatology, Vol. 79, Núm. 1, pp. 135-148

  3. Surgical management of adrenal carcinoma with inferior vena cava tumor thrombus

    Cirugia Espanola, Vol. 102, Núm. 3, pp. 175

  4. Textbook outcome in patients with biliary duct injury during cholecystectomy

    Journal of Gastrointestinal Surgery, Vol. 28, Núm. 5, pp. 725-730

  5. Textbook outcomes in the liver-first approach for colorectal liver metastases: prospective multicentre analysis

    BJS Open, Vol. 8, Núm. 1

  6. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

    Journal of Gastroenterology

  7. Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells

    Liver International, Vol. 44, Núm. 1, pp. 125-138

2023

  1. Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis

    Journal of Hepatology, Vol. 78, Núm. 4, pp. 794-804

  2. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS−/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

    NMR in Biomedicine, Vol. 36, Núm. 8

  3. Diversifying the concept of model organisms in the age of -omics

    Communications Biology, Vol. 6, Núm. 1

  4. Expanding the roles of the renin–angiotensin system: Drug-induced liver injury

    Journal of Hepatology

  5. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting

    Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8

  6. In Vivo Hepatic Triglyceride Secretion Rate in Antisense Oligonucleotide (ASO)-Treated Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2675, pp. 15-26

  7. In Vivo Tissue Lipid Uptake in Antisense Oligonucleotide (ASO)-Treated Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2675, pp. 1-13

  8. Insights into the mechanism of action of the chlorophyll derivative 13-2-hydroxypheophytine a on reducing neutral lipid reserves in zebrafish larvae and mice adipocytes

    European Journal of Pharmacology, Vol. 960

  9. Intraductal tubulopapillary neoplasm (ITPN) of the pancreas: A new entity different from intraductal mucinous neoplasm of the pancreas

    Cirugia Espanola, Vol. 101, Núm. 9, pp. 653-654

  10. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma

    Journal of Hepatology, Vol. 79, Núm. 1, pp. 93-108

  11. Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE

    The British journal of surgery, Vol. 110, Núm. 9, pp. 1161-1170

  12. Nonionic Surfactants can Modify the Thermal Stability of Globular and Membrane Proteins Interfering with the Thermal Proteome Profiling Principles to Identify Protein Targets

    Analytical Chemistry, Vol. 95, Núm. 8, pp. 4033-4042

  13. Prediction of Molecular Initiating Events for Adverse Outcome Pathways Using High-Throughput Identification of Chemical Targets

    Toxics, Vol. 11, Núm. 2